Burke.jpg

Kathy Burke

Vice President of Market Access

Kathy has served as Osteal Therapeutics since August 2022. She brings over 20 years of commercial leadership experience across medical device and biopharmaceuticals.  Previously, Kathy was Executive Director of Market Access at Spero Therapeutics, specializing in the anti-infective market. Previously, Kathy held commercial leadership positions with Flexion Therapeutics, Auxilium Pharmaceuticals, Regeneron and Zimmer. Her Market Access expertise includes MA strategy, government pricing, trade & distribution, coding, reimbursement and a certification in physician practice management (CPPM) from the American Academy of Professional Coders. 

Kathy received a BS in Economics & Chemistry from the University of Florida.